Combining bevacizumab and panitumumab with irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as second-line treatment in patients with metastatic colorectal cancer
Crossref DOI link: https://doi.org/10.1007/s12032-014-0976-6
Published Online: 2014-05-03
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liang, Hong-Liang
Hu, Ai-Ping
Li, Sen-Lin
Liu, Ji-Yong
Text and Data Mining valid from 2014-05-03